Actium Biosystems LLC
Thermal nanomedicine to treat bladder cancer
Executive Summary
The Actium Cancer Treatment System from Actium Biosystems LLC is designed to improve bladder cancer treatment by selectively heating chemotherapeutic agents within the body to drive them more deeply into tumors. Studies confirm that as much as four times the amount of drug reaches the cancer tumor with the addition of hyperthermia, compared with the standard of care for chemotherapy that does not use any heat and thus treats at the normal body temperature.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.